Your browser doesn't support javascript.
loading
Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review.
Ducos, Claire; Aba, Naïla; Rosselli, Filippo; Fresneau, Brice; Al Ahmad Nachar, Baraah; Zidane, Monia; de Vathaire, Florent; Benhamou, Simone; Haddy, Nadia.
Afiliación
  • Ducos C; Radiation Epidemiology Team, Center for Research in Epidemiology and Population Health, INSERM Unit 1018, University Paris Saclay, Villejuif, France.
  • Aba N; Radiation Epidemiology Team, Center for Research in Epidemiology and Population Health, INSERM Unit 1018, University Paris Saclay, Villejuif, France.
  • Rosselli F; CNRS UMR9019, Gustave Roussy Cancer Campus, Université Paris-Saclay, Equipe Labellisée Ligue Nationale Contre le Cancer Villejuif, France.
  • Fresneau B; Radiation Epidemiology Team, Center for Research in Epidemiology and Population Health, INSERM Unit 1018, University Paris Saclay, Villejuif, France.
  • Al Ahmad Nachar B; Department of Children and Adolescents Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.
  • Zidane M; CNRS UMR9019, Gustave Roussy Cancer Campus, Université Paris-Saclay, Equipe Labellisée Ligue Nationale Contre le Cancer Villejuif, France.
  • de Vathaire F; Radiation Epidemiology Team, Center for Research in Epidemiology and Population Health, INSERM Unit 1018, University Paris Saclay, Villejuif, France.
  • Benhamou S; Radiation Epidemiology Team, Center for Research in Epidemiology and Population Health, INSERM Unit 1018, University Paris Saclay, Villejuif, France.
  • Haddy N; Oncostat Team, Center for Research in Epidemiology and Population Health, INSERM Unit 1018, University Paris Saclay, Villejuif, France.
Cancer Epidemiol Biomarkers Prev ; 33(8): 999-1011, 2024 Aug 01.
Article en En | MEDLINE | ID: mdl-38801411
ABSTRACT
Second malignant neoplasm (SMN) is one of the most severe long-term risks for childhood cancer survivors (CCS), significantly impacting long-term patient survival. While radiotherapy and chemotherapy are known risk factors, the observed inter-individual variability suggests a genetic component contributing to the risk of SMN. This article aims to conduct a systematic review of genetic factors implicated in the SMN risk among CCS. Searches were performed in PubMed, Scopus, and Web of Sciences. Eighteen studies were included (eleven candidate gene studies, three genome-wide association studies, and four whole exome/genome sequencing studies). The included studies were based on different types of first cancers, investigated any or specific types of SMN, and focused mainly on genes involved in drug metabolism and DNA repair pathways. These differences in study design and methods used to characterize genetic variants limit the scope of the results and highlight the need for further extensive and standardized investigations. However, this review provides a valuable compilation of SMN risk-associated variants and genes, facilitating efficient replication and advancing our understanding of the genetic basis for this major risk for CCS.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias Límite: Child / Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias Límite: Child / Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos